Conference Coverage
Trending on the Eye Care Network
Latest News
Jul 22, 2026 | Publication
Suprachoroidal space injection for the treatment of noninfectious uveitis
Retina World Congress 2026 recap: Durability, diagnosis, discovery, and what’s next in retina care
Jul 21, 2026
Raising the next generation of retinal specialists
Jul 19, 2026
Rethinking OCT biomarkers in DME: Baseline acuity and thickness outperform the rest
Jul 18, 2026
Cynthia Toth, MD: What retinal imaging reveals about the preterm infant brain
Jul 16, 2026
Advertisement
Shorts
0:24
Where does the field stand on functional outcomes in geographic atrophy?
3 days ago
0:21
How do baseline vision-loss predictors from the ARCHER study change GA patient counseling?
4 days ago
0:55
How the ENCELTO implant works, explained by Dr. Wykoff
4 days ago
0:41
AXPAXLI's real-world potential to reduce wet AMD treatment gaps
5 days ago
0:24
AI's future role in retina care recordkeeping, imaging, and research
5 days ago
0:21
Which baseline characteristics predict vision loss in geographic atrophy?
5 days ago
1:00
AXPAXLI shows superiority in SOL-1 wet AMD trial
6 days ago
1:02
Margaret Chang, MD: AI in retinal imaging
8 days ago
0:47
Patient education in the AI era
9 days ago
0:51
How to follow patients after ENCELTO implantation
15 days ago
Digital Edition
Modern Retina
How this gene-agnostic optogenetic approach could fill a critical gap for advanced inherited retinal degeneration.
Modern Retina
Ultra-widefield imaging reveals early retinal risk in pediatric patients.
Modern Retina
SOL-1 results show intravitreal axitinib hydrogel delivered superior vision
maintenance and anatomic outcomes through 52 weeks.
Modern Retina
New pathways are reshaping the management of retinal disease.
Modern Retina
Imaging and biomarkers are driving earlier, more individualized GA treatment
Modern Retina
When no retina podcast was available, Jayanth Sridhar, MD, created one—and learned lessons about branding, bandwidth, and mentorship along the way.
Modern Retina
A trio of retina specialists recently reviewed the clinical benefits of aflibercept 8 mg, including its extended dosing intervals, improved patient satisfaction, and enhanced treatment outcomes for various conditions.
Modern Retina
Explore early MacTel diagnosis with OCT/FA, who qualifies for Encelto implant, and how costs, reimbursement, and surgery shape timely retina care.
Modern Retina
For Jordan M. Graff, MD, FACS, early adoption is about reigniting the thrill of discovery and navigating the rewards, risks, and realities of translating innovation into practice.
Podcasts
Continuing Medical Education
Advertisement
All News
Advertisement
A recap of the FDA approvals, phase 3 readouts, and pipeline data that shaped diabetic eye disease care in the first half of 2026.
Cascade Prodrug and Uneedle are partnering to test suprachoroidal delivery of CPD100 using Uneedle's Bella-Vue microneedle system for the treatment of wet AMD.
From a phase 3 durability readout for a first-in-class TKI to a new interchangeable ranibizumab biosimilar and a deep dive into geographic atrophy management, June brought a wide-ranging mix of regulatory, clinical, and practice-pattern news for retina specialists
How this gene-agnostic optogenetic approach could fill a critical gap for advanced inherited retinal degeneration.
Border zone lifetime gradient correlated with growth rate over 5 years
Varicella vaccine drove the largest risk reduction in a 5-vaccine, multi-million-patient analysis
Ultra-widefield imaging reveals early retinal risk in pediatric patients.
Three cases illustrate how next-generation anti-VEGF agents are extending treatment intervals and improving durability across retinal vascular disease.
SOL-1 results show intravitreal axitinib hydrogel delivered superior vision maintenance and anatomic outcomes through 52 weeks.
New IGF-1R antibody Lumvoa receives FDA nod for active and chronic thyroid eye disease, offering rapid proptosis relief and diplopia improvement.
Advertisement
A randomized trial found that 8 weeks of daily use of the Calm Health app significantly improved mental health outcomes in adults with non-infectious uveitis.
A prospective pilot study finds focal photopic microperimetry may detect cone-mediated losses that lesion size and visual acuity do not reflect.
Retina cells that sense light falter in Alzheimer’s, potentially derailing sleep and body clocks—pointing to new diagnostic and treatment angles.
StemSight secures new patents for scalable induced pluripotent stem cells-derived limbal stem cells, boosting STE-101’s path to off-the-shelf limbal stem cell deficiency therapy and upcoming Series A.
Learn how FDA’s interchangeable ranibizumab biosimilar may streamline injections, cut costs, and guide safe switching for retina patients.
Advertisement
Advertisement